© Copyright 2026, All Rights Reserved
University-backed innovation hub with AI-driven medical diagnostics and spinout ventures
Predict patient response to arthritis treatment using deep molecular phenotyping; Simulate blood flow in individual aortas with AI to guide TAVR procedures; Detect pre-eclampsia in early pregnancy with a blood test; Diagnose dementia with 80%+ accuracy up to nine years before symptoms; Enhance immunotherapy efficacy in lung cancer; Diagnose blood clotting issues in real time with portable biochips; Enable robotics to sense physical object properties with electronic skin; Provide appetite suppression via nutrient-based therapy elcella; Create sustainable packaging with biodegradable toothpaste tablets
Operates as Queen Mary University’s official technology transfer company; Manages 15+ active research projects; Has 8+ spinout companies in development; Portfolio includes AI-driven medical diagnostics and sustainable consumer products; Active in biopharma, engineering, and humanities innovation areas